,i  #aai? ,,congress  #b;d ,session  ,h4
 ,r4 #iajb  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,june #b1 #bjbf,mr4   
,mool5a> 7= himself & ,mrs4 ,d+ell7     
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,f9ancial ,s]vices  ,a 
,,bill  ,to am5d title ,,viii ( !       
,def5se ,production ,act ( #aiej to alt]
 ! def9itions ( prohibit$ te*nology &   
notifiable te*nology1 & = o!r purposes4 
#a4 ,%ort title ,?is ,act may be cit$ at
 ! ,biote* ,inve/m5t ,national ,security
 ,act ( #bjbf or ! ,,b9sa ,act4  #b4    
,f9d+s ,! ,congress f9ds ! foll[+3 7#a7 
,*9a has pursu$ a delib]ate1            
/ate-direct$ /rategy to dom9ate global  
biote*nology1 includ+ ph>maceutical     
developm5t1 biologics manufactur+1 &    
cl9ical rese>* & developm5t             
capabilities4  7#b7 ,unit$ ,/ates       
capital fl[+ to ,*9ese biote*nology     
companies ?r\gh lic5s+ agreem5ts1 jo9t  
v5tures1 & equity inve/m5ts is accel]at+
 ,*9a's acquisition ( ph>maceutical     
intellectual prop]ty & cl9ical          

developm5t capabilities 9 a mann] t     
creates /rategic dep5d5cy risks = !     
,unit$ ,/ates4  7#c7 ,cross-bord]       
out-lic5s+ transactions betwe5 ,unit$   
,/ates & ,european ph>maceutical        
companies & ,*9ese biote*nology firms   
total$ approximately #acf1jjj1jjj1jjj 9 
#bjbe1 repres5t+ a rapid & accel]at+    
transf] ( ph>maceutical innovation      
capacity to entities subject to !       
direction & control ( ! ,p's ,republic (
 ,*9a4  7#d7 ,biote*nology1 includ+     
ph>maceutical developm5t & biologics    
manufactur+1 has civil-milit>y dual-use 
applications & pres5ts /rategic dep5d5cy
 risks = ! ,unit$ ,/ates comp>able to ^?
 pres5t$ by semiconductors1 artificial  
intellig5ce1 & o!r te*nologies already  
cov]$ "u title ,,viii ( ! ,def5se       
,production ,act ( #aiej4  7#e7 ,!      
,,biosecure ,act1 enact$ z "p ( !       
,national ,def5se ,au?orization ,act =  
,fiscal ,ye> #bjbf1 recogniz$ t         
biote*nology is bo? a national security 
asset & a /rategic vuln]ability1 & t !  

,p's ,republic ( ,*9a seeks to dom9ate  
biote*nology z an indu/ry ( ! future4   
7#f7 ,consi/5t application ( outb\nd    
inve/m5t scre5+ to biote*nology is      
necess>y to prev5t ,unit$ ,/ates capital
 & intellectual prop]ty f accel]at+     
,*9a's dom9ance ( ! ph>maceutical       
innovation supply *a9 9 a mann] t w     
create long-t]m /rategic dep5d5cy risks 
analog\s to ^? ! ,unit$ ,/ates n[ faces 
9 r>e e>? elem5ts & semiconductors4  #c4
 ,am5dm5ts ,section #hji ( ! ,def5se    
,production ,act ( #aiej 7#ej ,u4,s4,c4 
#dehi7 is am5d$-- 7#a7 9 p>agraph       
7#aj77;,a71 by add+ at ! end ! foll[+3  
7vi7 ,biote*nology1 mean+ ! rese>*1     
developm5t1 manufactur+1 or             
comm]cialization (-- 7,i7 ph>maceutical 
products 7:i* has ! mean+ giv5 ! t]m    
drug 9 section #bja7;g77#a7 ( ! ,f$]al  
,food1 ,drug1 & ,cosmetic ,act 7#ba     
,u4,s4,c4 #cba7;g77#a7772  7,,ii7       
biological products 7z su* t]m is def9$ 
9 section #cea7;i7 ( ! ,public ,heal?   
,s]vice ,act 7#db ,u4,s4,c4 #bfb7;i7772 

&  7,,iii7 !rapeutic comp\nds1 includ+  
drug discov]y plat=ms1 cl9ical rese>* & 
developm5t capabilities1 biologics      
manufactur+1 & intellectual prop]ty &   
"k-h[ relat+ to !rapeutic comp\nds1  2  
7#b7 9 p>agraph 7#g77;,a71 by add+ at ! 
end ! foll[+3  7vi7 ,biote*nology1 mean+
 ! rese>*1 developm5t1 manufactur+1 or  
comm]cialization (-- 7,i7 ph>maceutical 
products 7:i* has ! mean+ giv5 ! t]m    
drug 9 section #bja7;g77#a7 ( ! ,f$]al  
,food1 ,drug1 & ,cosmetic ,act 7#ba     
,u4,s4,c4 #cba7;g77#a7772  7,,ii7       
biological products 7z su* t]m is def9$ 
9 section #cea7;i7 ( ! ,public ,heal?   
,s]vice ,act 7#db ,u4,s4,c4 #bfb7;i7772 
&  7,,iii7 !rapeutic comp\nds1 includ+  
drug discov]y plat=ms1 cl9ical rese>* & 
developm5t capabilities1 biologics      
manufactur+1 & intellectual prop]ty &   
"k-h[ relat+ to !rapeutic comp\nds1  2 &
  7#c7 9 p>agraph 7#d77;,a71 by add+ at 
! end ! foll[+3  7ix7 lic5s+ a prohibit$
 te*nology f a cov]$ =eign p]son4  4    
#d4 ,rulemak+  7a7 ,9 g5]al ,! ,secret>y

 ( ! ,treasury %all1 n lat] ?an #a ye>  
aft] ! date ( ! enactm5t ( ?is ,act1    
issue a rule to fur!r def9e ! p>amet]s (
 ! area ( biote*nology z x is us$ 9     
p>agraphs 7#g77;,a7 & 7#aj77;,a7 ( !    
,def5se ,production ,act ( #aiej1 z     
am5d$ by ?is ,act4  7b7 ,requirem5ts ,:5
 def9+ ! p>amet]s ( ! area (            
biote*nology pursuant to subsection 7a71
 ! ,secret>y ( ! ,treasury %all-- 7#a7  
consult ) ! ,secret>y ( ,heal? & ,human 
,s]vices1 ! ,secret>y ( ,def5se1 & !    
,director ( ,national ,intellig5ce2     
7#b7 give p>ticul> consid]ation to      
transactions involv+ ! lic5s+ (         
intellectual prop]ty1 drug discov]y     
plat=ms1 cl9ical rese>* & developm5t    
capabilities1 & biologics manufactur+   
"k-h[ to cov]$ =eign p]sons 7z su* t]m  
is def9$ 9 section #hji ( ! ,def5se     
,production ,act ( #aiej72  7#c7 give   
p>ticul> consid]ation to lic5s+         
transactions1 jo9t v5tures1 & equity    
inve/m5ts involv+ drug discov]y plat=ms1
 cl9ical developm5t capabilities1 &     

biologics manufactur+ z priority        
categories = bo? ! prohibit$ &          
notifiable te*nology ti]s )9 !          
biote*nology sector2  7#d7 consid] !    
degree to :i* a transaction w\ld transf]
 ph>maceutical innovation capacity1     
cl9ical developm5t capabilities1 or     
manufactur+ "k-h[ to entities subject to
 ! direction or control ( ! ,p's        
,republic ( ,*9a2  7#e7 def9e !         
biote*nology sector to include ! rese>*1
 developm5t1 manufactur+1 &             
comm]cialization ( ph>maceutical        
products1 biological products1 &        
!rapeutic comp\nds1 includ+ drug        
discov]y plat=ms1 cl9ical rese>* &      
developm5t capabilities1 biologics      
manufactur+1 & relat$ intellectual      
prop]ty & "k-h[ transf]s2 &  7#f7 n     
def9e ! biote*nology sector 9 a mann] t 
includes or c\ld be con/ru$ to include  
agricultural biote*nology1 indu/rial    
f]m5tation unrelat$ to ph>maceutical or 
!rapeutic production1 or basic academic 
rese>* ) no direct ph>maceutical or     

!rapeutic application4  #e4 ,report     
requir$  7a7 ,9 g5]al ,n lat] ?an #fj   
days aft] ! date ( ! enactm5t ( ?is     
,act1 ! ,secret>y ( ,def5se %all submit 
a report to ! appropriate congressional 
committees assess+ :e!r fl[s ( ,unit$   
,/ates capital into ,*9a's biote*nology 
sector1 includ+ ?r\gh lic5s+            
transactions ) ,*9ese biote*nology      
firms1 negatively affect ,unit$ ,/ates  
national security & milit>y read9ess4   
7b7 ,=m ,! report describ$ 9 subsection 
7a7 %all be submitt$ 9 unclassifi$ =m b 
may include a classifi$ annex4  7c7     
,appropriate congressional committees   
def9$ ,! t]m appropriate congressional  
committees means-- 7#a7 ! ,committee on 
,arm$ ,s]vices ( ! ,h\se (              
,repres5tatives2  7#b7 ! ,committee on  
,f9ancial ,s]vices ( ! ,h\se (          
,repres5tatives2  7#c7 ! ,p]man5t       
,select ,committee on ,intellig5ce ( !  
,h\se ( ,repres5tatives2  7#d7 ! ,select
 ,committee on ! ,/rategic ,competition 
betwe5 ! ,unit$ ,/ates & ! ,*9ese       

,communi/ ,p>ty ( ! ,h\se (             
,repres5tatives2  7#e7 ! ,committee on  
,arm$ ,s]vices ( ! ,s5ate2  7#f7 !      
,committee on ,bank+1 ,h\s+1 & ,urban   
,affairs ( ! ,s5ate2 &  7#g7 ! ,select  
,committee on ,intellig5ce ( ! ,s5ate4